InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO Talks New Cvergenx Partnership During Proactive Interview
Predictive Oncology (NASDAQ: POAI) CEO Raymond Vennare was a featured guest during the latest interview released by Proactive US. Vennare joined Cvergenx CEO Javier Torres-Roca to talk about the recent announcement that the two companies have joined forces to create a new genomic-based artificial intelligence (“AI”) radiation therapy. Host Natalie Stoberman facilitated the discussion, in which the two execs discussed the development of the first-ever…